{"DataElement":{"publicId":"7590849","version":"1","preferredName":"Overall Evaluation Multiple Parameter Disease or Disorder Status","preferredDefinition":"An indication of the overall disease status using a combination of criteria.","longName":"OVL_MULT_PARAM_DSZ_STATUS","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7590842","version":"1","preferredName":"Overall Evaluation Multiple Parameter Disease or Disorder Status","preferredDefinition":"Including everything._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._A Parameter is a replaceable value in a Parameterizable class.  Examples of Parameters include: scanning wavelength, laser power, centrifuge speed, multiplicative errors, the number of input nodes to a SOM, and PCR temperatures._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"7590839v1.0:7590840v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"7590839","version":"1","preferredName":"Overall Evaluation","preferredDefinition":"Including everything.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"C25605:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCE20DB-DBDF-4907-E053-4EBD850AF6C5","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"ONEDATA","dateModified":"2021-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7590840","version":"1","preferredName":"Multiple Parameter Disease or Disorder Status","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.:A Parameter is a replaceable value in a Parameterizable class.  Examples of Parameters include: scanning wavelength, laser power, centrifuge speed, multiplicative errors, the number of input nodes to a SOM, and PCR temperatures.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A condition or state at a particular time.","longName":"C17648:C44175:C2991:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Parameter","conceptCode":"C44175","definition":"Any factor that defines a system and determines (or limits) its performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCE20DB-DBF2-4907-E053-4EBD850AF6C5","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"ONEDATA","dateModified":"2021-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCE20DB-DC03-4907-E053-4EBD850AF6C5","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"SPRINGERL","dateModified":"2021-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7589378","version":"1","preferredName":"Multiple Parameter Disease Response Status","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._A Parameter is a replaceable value in a Parameterizable class.  Examples of Parameters include: scanning wavelength, laser power, centrifuge speed, multiplicative errors, the number of input nodes to a SOM, and PCR temperatures._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._A condition or state at a particular time.","longName":"7589378v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"500","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CR/PR with normalization of tumor markers","valueDescription":"Complete Remission Or Partial Remission With Normal Tumor Marker","ValueMeaning":{"publicId":"7589379","version":"1","preferredName":"Complete Remission Or Partial Remission With Normal Tumor Marker","longName":"7589379","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.: Used to indicate the presence of something or someone.: Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA516C9-6D52-6382-E053-4EBD850A96F6","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA58D52-F389-7063-E053-4EBD850AD5DF","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"Less than CR/PR with normalization of tumor markers","valueDescription":"Less Than Complete Remission Or Partial Remission With Normal Tumor Marker","ValueMeaning":{"publicId":"7589442","version":"1","preferredName":"Less Than Complete Remission Or Partial Remission With Normal Tumor Marker","longName":"7589442","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: The disappearance of all signs of cancer in response to treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.: Used to indicate the presence of something or someone.: Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA52952-85EC-05A3-E053-4EBD850A9B06","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA58D52-F39D-7063-E053-4EBD850AD5DF","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"CR without normalization of tumor markers","valueDescription":"Complete Remission Without Normal Tumor Marker","ValueMeaning":{"publicId":"7589439","version":"1","preferredName":"Complete Remission Without Normal Tumor Marker","longName":"7589439","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.: Used to indicate the absence or lack of something or someone.: Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA52952-856E-05A3-E053-4EBD850A9B06","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA52952-8587-05A3-E053-4EBD850A9B06","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"Progressive Disease","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"3284666","version":"1","preferredName":"Progressive Disease","longName":"3284666v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9FC7D6-531D-BE97-E040-BB89AD437875","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2023.5.17 Alt VM added per ticket request CADSR0002435. ak \r\n2023.3.15 Per LS at COG Protocol defined progressive disease (should have been added as a VM Alt Name for PV 3284666). ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA52952-8555-05A3-E053-4EBD850A9B06","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"Unable to Assess","valueDescription":"Cannot Be Assessed","ValueMeaning":{"publicId":"2897789","version":"1","preferredName":"Cannot Be Assessed","longName":"2897789","preferredDefinition":"Aspects of the context prevent the evaluation needed to determine a value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B943018-A5FF-1429-E040-BB89AD4312C2","latestVersionIndicator":"Yes","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA52952-855F-05A3-E053-4EBD850A9B06","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"PR without normalization of tumor markers","valueDescription":"Partial Remission Without Normal Tumor Marker","ValueMeaning":{"publicId":"7589440","version":"1","preferredName":"Partial Remission Without Normal Tumor Marker","longName":"7589440","preferredDefinition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.: Used to indicate the absence or lack of something or someone.: Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA52952-8596-05A3-E053-4EBD850A9B06","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA52952-85AF-05A3-E053-4EBD850A9B06","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"Less than CR/PR without normalization of tumor markers","valueDescription":"Less Than Complete Remission Or Partial Remission With Abnormal Tumor Marker","ValueMeaning":{"publicId":"7589441","version":"1","preferredName":"Less Than Complete Remission Or Partial Remission With Abnormal Tumor Marker","longName":"7589441","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: The disappearance of all signs of cancer in response to treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.: Used to indicate the presence of something or someone.: Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA52952-85C1-05A3-E053-4EBD850A9B06","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA52952-85DA-05A3-E053-4EBD850A9B06","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7589377","version":"1","preferredName":"Multiple Parameter Disease Response Status","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.:A Parameter is a replaceable value in a Parameterizable class.  Examples of Parameters include: scanning wavelength, laser power, centrifuge speed, multiplicative errors, the number of input nodes to a SOM, and PCR temperatures.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:A condition or state at a particular time.","longName":"C17648:C44175:C50995:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Parameter","conceptCode":"C44175","definition":"Any factor that defines a system and determines (or limits) its performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA516C9-6D23-6382-E053-4EBD850A96F6","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA516C9-6D34-6382-E053-4EBD850A96F6","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-03","modifiedBy":"SPRINGERL","dateModified":"2021-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Overall Disease Status:","type":"Preferred Question Text","description":"Overall Disease Status:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCD2903-FF20-792A-E053-4EBD850A083E","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"SPRINGERL","dateModified":"2021-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}